Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-risk Plasma Cell Neoplasms”

440 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 440 results

Early research (Phase 1)Study completedNCT03602235
What this trial is testing

High Dose Ascorbic Acid for Plasma Cell Disorders

Who this might be right for
Multiple Myeloma
Christopher Strouse 6
Not applicableStudy completedNCT01653106
What this trial is testing

Randomized Trial of Cryotherapy Duration Prior to High Dose Melphalan in Myeloma Patients

Who this might be right for
Refractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+1 more
Ohio State University Comprehensive Cancer Center 148
Not applicableUnknownNCT03704597
What this trial is testing

Cryotherapy Against Oral Mucositis After High-dose Melphalan

Who this might be right for
MyelomaMucositisCryotherapy Effect
Sahlgrenska University Hospital 100
Not applicableStudy completedNCT03234335
What this trial is testing

High Dose Therapy Followed by Autologous Transplantation for Myeloma Patients With Severe Renal Impairment

Who this might be right for
Multiple MyelomaRenal Failure
Centre Hospitalier Universitaire de Saint Etienne 50
Testing effectiveness (Phase 2)Study completedNCT02169791
What this trial is testing

Nonmyeloablative Haploidentical Transplant Followed by MLN9708

Who this might be right for
Acute LeukemiaChronic LeukemiaMyelodysplastic Syndrome+2 more
Northside Hospital, Inc. 29
Large-scale testing (Phase 3)Looking for participantsNCT06588413
What this trial is testing

Olanzapine 2.5 vs 5 mg in Quadruplet Nausea/Vomiting Prophylaxis Before High-Dose Melphalan

Who this might be right for
Multiple MyelomaAutologous Stem Cell Transplantation
Augusta University 172
Early research (Phase 1)Ended earlyNCT00376519
What this trial is testing

Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+3 more
Masonic Cancer Center, University of Minnesota 3
Testing effectiveness (Phase 2)Study completedNCT01572480
What this trial is testing

Carfilzomib, Lenalidomide, and Dexamethasone for Smoldering Multiple Myeloma

Who this might be right for
Multiple Myeloma
National Cancer Institute (NCI) 55
Not applicableStudy completedNCT00296023
What this trial is testing

Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
University of California, San Francisco 25
Testing effectiveness (Phase 2)Looking for participantsNCT05776979
What this trial is testing

Post-Transplant Maintenance Therapy With Isatuximab Plus Lenalidomide for High-Risk Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
M.D. Anderson Cancer Center 61
Large-scale testing (Phase 3)Study completedNCT00008229
What this trial is testing

Melphalan With or Without Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00003007
What this trial is testing

Interferon Alfa Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
University of Tennessee
Not applicableLooking for participantsNCT05866757
What this trial is testing

Discontinuation Study

Who this might be right for
Multiple MyelomaCancerHematologic Cancer
University College Cork 70
Early research (Phase 1)Study completedNCT00477035
What this trial is testing

Post-transplant Autologous Cytokine-induced Killer (CIK) Cells for Treatment of High Risk Hematologic Malignancies

Who this might be right for
LeukemiaMultiple Myeloma
Sally Arai 22
Testing effectiveness (Phase 2)Ended earlyNCT01534143
What this trial is testing

High Dose Busulfan and Bortezomib in Treating Patients With High Risk Multiple Myeloma Undergoing Stem Cell Transplant

Who this might be right for
Refractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+1 more
Barbara Ann Karmanos Cancer Institute 1
Early research (Phase 1)Study completedNCT02332850
What this trial is testing

Phase Ib Study of SAR650984 in Combination With Carfilzomib for Treatment of Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Thomas Martin, MD 83
Testing effectiveness (Phase 2)Ended earlyNCT00143884
What this trial is testing

Study of Low Intensity Conditioning and Immunotherapy for High-Risk Cancers of the Blood

Who this might be right for
LeukemiaLymphoma, Low-GradeLymphoma, Non-Hodgkin's+2 more
University of Michigan Rogel Cancer Center 30
Not applicableStudy completedNCT01314963
What this trial is testing

Efficacy of Gamma Camera Used Intraoperatively for ID of Sentinel Lymph Nodes w/ Lymphoscintigraphy

Who this might be right for
Multiple MyelomaBreast Cancer
Stanford University 50
Large-scale testing (Phase 3)Looking for participantsNCT07285239
What this trial is testing

Belantamab Mafodotin or Daratumumab With Bortezomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
PrECOG, LLC. 500
Testing effectiveness (Phase 2)Ended earlyNCT00698685
What this trial is testing

Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation

Who this might be right for
LeukemiaLymphomaHodgkin's Disease+3 more
University of Arizona 14
Next Page